{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:44:41Z","timestamp":1794037481241,"version":"4.8.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030E_221942 & 310030_212190"],"award-info":[{"award-number":["320030E_221942 & 310030_212190"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["513025799\/FOR5621"],"award-info":[{"award-number":["513025799\/FOR5621"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["513025799\/FOR5621"],"award-info":[{"award-number":["513025799\/FOR5621"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Research Priority Program of the University of Zurich (URPP) ITINERARE \u2013 Innovative Therapies in Rare Diseases","id":[{"id":"https:\/\/ror.org\/02crff812","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41596-025-01243-8","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:01:44Z","timestamp":1757577704000},"page":"1466-1522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dual AAV vectors for efficient delivery of large transgenes"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9554-3033","authenticated-orcid":false,"given":"David M.","family":"Mittas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Riedmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Gavrilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9354-5014","authenticated-orcid":false,"given":"Valentin J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Y.","family":"Otify","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Mehlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6421-2553","authenticated-orcid":false,"given":"Balint","family":"Szalontai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Ucambarlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7660-3485","authenticated-orcid":false,"given":"Catharina","family":"Gandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1571-8579","authenticated-orcid":false,"given":"Thomas","family":"Heigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Biel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvir","family":"Becirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"1243_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1243_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li, C. & Samulski, R. J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255\u2013272 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"1243_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26518-y","volume":"12","author":"R Ibraheim","year":"2021","unstructured":"Ibraheim, R. et al. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo. Nat. Commun. 12, 6267 (2021).","journal-title":"Nat. Commun."},{"key":"1243_CR4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41587-022-01648-w","volume":"41","author":"MJ Jang","year":"2023","unstructured":"Jang, M. J. et al. Spatial transcriptomics for profiling the tropism of viral vectors in tissues. Nat. Biotechnol. 41, 1272\u20131286 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1243_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnmol.2020.00148","volume":"13","author":"JE Rittiner","year":"2020","unstructured":"Rittiner, J. E., Moncalvo, M., Chiba-Falek, O. & Kantor, B. Gene-editing technologies paired with viral vectors for translational research into neurodegenerative diseases. Front. Mol. Neurosci. 13, 148 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"1243_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","volume":"21","author":"A Srivastava","year":"2016","unstructured":"Srivastava, A. In vivo tissue-tropism of adeno-associated viral vectors. Curr. Opin. Virol. 21, 75\u201380 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"1243_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40265-023-01845-0","volume":"83","author":"YA Heo","year":"2023","unstructured":"Heo, Y. A. Etranacogene dezaparvovec: first approval. Drugs 83, 347\u2013352 (2023).","journal-title":"Drugs"},{"key":"1243_CR8","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.2147\/OPTH.S231804","volume":"14","author":"J Gao","year":"2020","unstructured":"Gao, J., Hussain, R. M. & Weng, C. Y. Voretigene neparvovec in retinal diseases: a review of the current clinical evidence. Clin. Ophthalmol. 14, 3855\u20133869 (2020).","journal-title":"Clin. Ophthalmol."},{"key":"1243_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s40265-023-01929-x","volume":"83","author":"SM Hoy","year":"2023","unstructured":"Hoy, S. M. Delandistrogene moxeparvovec: first approval. Drugs 83, 1323\u20131329 (2023).","journal-title":"Drugs"},{"key":"1243_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80\u201386 (2010).","journal-title":"Mol. Ther."},{"key":"1243_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso, M. F., Tomkowicz, B., Perry, W. L. & Strohl, W. R. Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs 31, 317\u2013334 (2017).","journal-title":"BioDrugs"},{"key":"1243_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/nbt1153","volume":"23","author":"Y Lai","year":"2005","unstructured":"Lai, Y. et al. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat. Biotechnol. 23, 1435\u20131439 (2005).","journal-title":"Nat. Biotechnol."},{"key":"1243_CR13","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1073\/pnas.97.12.6716","volume":"97","author":"Z Yan","year":"2000","unstructured":"Yan, Z., Zhang, Y., Duan, D. & Engelhardt, J. F. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl Acad. Sci. USA 97, 6716\u20136721 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1243_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/gt.2013.3","volume":"20","author":"VS Lopes","year":"2013","unstructured":"Lopes, V. S. et al. Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus. Gene Ther. 20, 824\u2013833 (2013).","journal-title":"Gene Ther."},{"key":"1243_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1006\/mthe.2001.0456","volume":"4","author":"D Duan","year":"2001","unstructured":"Duan, D., Yue, Y. & Engelhardt, J. F. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther. 4, 383\u2013391 (2001).","journal-title":"Mol. Ther."},{"key":"1243_CR16","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1093\/hmg\/ddv386","volume":"24","author":"I Trapani","year":"2015","unstructured":"Trapani, I. et al. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease. Hum. Mol. Genet. 24, 6811\u20136825 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"1243_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/sj.mt.6300322","volume":"16","author":"A Ghosh","year":"2008","unstructured":"Ghosh, A., Yue, Y., Lai, Y. & Duan, D. A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol. Ther. 16, 124\u2013130 (2008).","journal-title":"Mol. Ther."},{"key":"1243_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fnins.2017.00503","volume":"11","author":"LS Carvalho","year":"2017","unstructured":"Carvalho, L. S. et al. Evaluating efficiencies of dual AAV approaches for retinal targeting. Front. Neurosci. 11, 503 (2017).","journal-title":"Front. Neurosci."},{"key":"1243_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/hgtb.2013.212","volume":"25","author":"FM Dyka","year":"2014","unstructured":"Dyka, F. M., Boye, S. L., Chiodo, V. A., Hauswirth, W. W. & Boye, S. E. Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A. Hum. Gene Ther. Methods 25, 166\u2013177 (2014).","journal-title":"Hum. Gene Ther. Methods"},{"key":"1243_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42386-0","volume":"14","author":"LM Riedmayr","year":"2023","unstructured":"Riedmayr, L. M. et al. mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy. Nat. Commun. 14, 6578 (2023).","journal-title":"Nat. Commun."},{"key":"1243_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nbt0102-47","volume":"20","author":"X Liu","year":"2002","unstructured":"Liu, X. et al. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat. Biotechnol. 20, 47\u201352 (2002).","journal-title":"Nat. Biotechnol."},{"key":"1243_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1126\/science.adp8179","volume":"386","author":"SR Lindley","year":"2024","unstructured":"Lindley, S. R. et al. Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies. Science 386, 762\u2013767 (2024).","journal-title":"Science"},{"key":"1243_CR23","doi-asserted-by":"crossref","unstructured":"Tornabene, P. et al. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci. Transl. Med. 11, eaav4523 (2019).","DOI":"10.1126\/scitranslmed.aav4523"},{"key":"1243_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40263-022-00941-1","volume":"36","author":"HA Blair","year":"2022","unstructured":"Blair, H. A. Onasemnogene abeparvovec: a review in spinal muscular atrophy. CNS Drugs 36, 995\u20131005 (2022).","journal-title":"CNS Drugs"},{"key":"1243_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.omtn.2023.05.014","volume":"32","author":"A Srivastava","year":"2023","unstructured":"Srivastava, A. Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy. Mol. Ther. Nucleic Acids 32, 949\u2013959 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1243_CR26","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkac958","volume":"51","author":"FJ Martin","year":"2023","unstructured":"Martin, F. J. et al. Ensembl 2023. Nucleic Acids Res. 51, D933\u2013D941 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1243_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.molmed.2018.06.006","volume":"24","author":"I Trapani","year":"2018","unstructured":"Trapani, I. & Auricchio, A. Seeing the light after 25 years of retinal gene therapy. Trends Mol. Med. 24, 669\u2013681 (2018).","journal-title":"Trends Mol. Med."},{"key":"1243_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fimmu.2013.00261","volume":"4","author":"K Willett","year":"2013","unstructured":"Willett, K. & Bennett, J. Immunology of AAV-mediated gene transfer in the eye. Front. Immunol. 4, 261 (2013).","journal-title":"Front. Immunol."},{"key":"1243_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41596-021-00666-3","volume":"17","author":"LM Riedmayr","year":"2022","unstructured":"Riedmayr, L. M. et al. dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy. Nat. Protoc. 17, 781\u2013818 (2022).","journal-title":"Nat. Protoc."},{"key":"1243_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nmeth.3312","volume":"12","author":"A Chavez","year":"2015","unstructured":"Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12, 326\u2013328 (2015).","journal-title":"Nat. Methods"},{"key":"1243_CR31","doi-asserted-by":"crossref","unstructured":"Yeo, N. C. et al. An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat. Methods 15, 611\u2013616 (2018).","DOI":"10.1038\/s41592-018-0048-5"},{"key":"1243_CR32","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK Nunez","year":"2021","unstructured":"Nunez, J. K. et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell 184, 2503\u20132519 e17 (2021).","journal-title":"Cell"},{"key":"1243_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45969-7","volume":"15","author":"E Zhang","year":"2024","unstructured":"Zhang, E., Neugebauer, M. E., Krasnow, N. A. & Liu, D. R. Phage-assisted evolution of highly active cytosine base editors with enhanced selectivity and minimal sequence context preference. Nat. Commun. 15, 1697 (2024).","journal-title":"Nat. Commun."},{"key":"1243_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41589-022-01163-8","volume":"19","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Engineering a precise adenine base editor with minimal bystander editing. Nat. Chem. Biol. 19, 101\u2013110 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"1243_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"1243_CR36","doi-asserted-by":"publisher","first-page":"eaba5614","DOI":"10.1126\/sciadv.aba5614","volume":"6","author":"S Bohm","year":"2020","unstructured":"Bohm, S. et al. A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activation. Sci. Adv. 6, eaba5614 (2020).","journal-title":"Sci. Adv."},{"key":"1243_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1243_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41587-023-01758-z","volume":"42","author":"JR Davis","year":"2024","unstructured":"Davis, J. R. et al. Efficient prime editing in mouse brain, liver and heart with dual AAVs. Nat. Biotechnol. 42, 253\u2013264 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1243_CR39","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s42003-022-04152-8","volume":"5","author":"F Chen","year":"2022","unstructured":"Chen, F. et al. Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors. Commun. Biol. 5, 1163 (2022).","journal-title":"Commun. Biol."},{"key":"1243_CR40","doi-asserted-by":"crossref","unstructured":"Schmitt-Ulms, C. et al. Programmable RNA writing with trans-splicing. Preprint at bioRxiv (2024).","DOI":"10.1101\/2024.01.31.578223"},{"key":"1243_CR41","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An, M. et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. 42, 1526\u20131537 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1243_CR42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265.e16 (2022).","journal-title":"Cell"},{"key":"1243_CR43","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","volume":"13","author":"JA Kulkarni","year":"2017","unstructured":"Kulkarni, J. A. et al. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine 13, 1377\u20131387 (2017).","journal-title":"Nanomedicine"},{"key":"1243_CR44","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/acsptsci.3c00185","volume":"6","author":"D Pozzi","year":"2023","unstructured":"Pozzi, D. & Caracciolo, G. Looking Back, moving forward: lipid nanoparticles as a promising frontier in gene delivery. ACS Pharmacol. Transl. Sci. 6, 1561\u20131573 (2023).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"1243_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.omtm.2022.02.011","volume":"25","author":"JR Mendell","year":"2022","unstructured":"Mendell, J. R. et al. Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations. Mol. Ther. Methods Clin. Dev. 25, 74\u201383 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1243_CR46","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","volume":"31","author":"D Duan","year":"2023","unstructured":"Duan, D. Lethal immunotoxicity in high-dose systemic AAV therapy. Mol. Ther. 31, 3123\u20133126 (2023).","journal-title":"Mol. Ther."},{"key":"1243_CR47","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","volume":"25","author":"JC van der Loo","year":"2016","unstructured":"van der Loo, J. C. & Wright, J. F. Progress and challenges in viral vector manufacturing. Hum. Mol. Genet. 25, R42\u2013R52 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1243_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35637-z","volume":"14","author":"X Han","year":"2023","unstructured":"Han, X. et al. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis. Nat. Commun. 14, 75 (2023).","journal-title":"Nat. Commun."},{"key":"1243_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"},{"key":"1243_CR50","doi-asserted-by":"crossref","unstructured":"Kularatne, R. N., Crist, R. M. & Stern, S. T. The future of tissue-targeted lipid nanoparticle-mediated nucleic acid delivery. Pharmaceuticals 15, 897 (2022).","DOI":"10.3390\/ph15070897"},{"key":"1243_CR51","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni, J. A. et al. The current landscape of nucleic acid therapeutics. Nat. Nanotechnol. 16, 630\u2013643 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"1243_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med."},{"key":"1243_CR53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-020-0565-5","volume":"38","author":"J van Haasteren","year":"2020","unstructured":"van Haasteren, J., Li, J., Scheideler, O. J., Murthy, N. & Schaffer, D. V. The delivery challenge: fulfilling the promise of therapeutic genome editing. Nat. Biotechnol. 38, 845\u2013855 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1243_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","volume":"25","author":"DL Wagner","year":"2019","unstructured":"Wagner, D. L. et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat. Med. 25, 242\u2013248 (2019).","journal-title":"Nat. Med."},{"key":"1243_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","volume":"4","author":"CS Lee","year":"2017","unstructured":"Lee, C. S. et al. Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes Dis. 4, 43\u201363 (2017).","journal-title":"Genes Dis."},{"key":"1243_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep44775","volume":"7","author":"JR Counsell","year":"2017","unstructured":"Counsell, J. R. et al. Lentiviral vectors can be used for full-length dystrophin gene therapy. Sci. Rep. 7, 44775 (2017).","journal-title":"Sci. Rep."},{"key":"1243_CR57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/ng0892-372","volume":"1","author":"HA Jaffe","year":"1992","unstructured":"Jaffe, H. A. et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1, 372\u2013378 (1992).","journal-title":"Nat. Genet."},{"key":"1243_CR58","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.2017680","volume":"252","author":"MA Rosenfeld","year":"1991","unstructured":"Rosenfeld, M. A. et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431\u2013434 (1991).","journal-title":"Science"},{"key":"1243_CR59","doi-asserted-by":"publisher","first-page":"E3503","DOI":"10.1073\/pnas.1208972109","volume":"109","author":"DE Zak","year":"2012","unstructured":"Zak, D. E. et al. Merck Ad5\/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity. Proc. Natl Acad. Sci. USA 109, E3503\u2013E3512 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1243_CR60","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1128\/JVI.01392-12","volume":"87","author":"R Khare","year":"2013","unstructured":"Khare, R., Hillestad, M. L., Xu, Z., Byrnes, A. P. & Barry, M. A. Circulating antibodies and macrophages as modulators of adenovirus pharmacology. J. Virol. 87, 3678\u20133686 (2013).","journal-title":"J. Virol."},{"key":"1243_CR61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","volume":"80","author":"SE Raper","year":"2003","unstructured":"Raper, S. E. et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148\u2013158 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"1243_CR62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"JL Shirley","year":"2020","unstructured":"Shirley, J. L., de Jong, Y. P., Terhorst, C. & Herzog, R. W. Immune responses to viral gene therapy vectors. Mol. Ther. 28, 709\u2013722 (2020).","journal-title":"Mol. Ther."},{"key":"1243_CR63","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.12659\/MSM.903094","volume":"23","author":"W Qian","year":"2017","unstructured":"Qian, W. et al. Prolonged integration site selection of a lentiviral vector in the genome of human keratinocytes. Med. Sci. Monit. 23, 1116\u20131122 (2017).","journal-title":"Med. Sci. Monit."},{"key":"1243_CR64","doi-asserted-by":"crossref","unstructured":"Wu, C. & Dunbar, C. E. Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity. Front. Med. 5, 356\u2013371 (2011).","DOI":"10.1007\/s11684-011-0159-1"},{"key":"1243_CR65","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1172\/JCI62189","volume":"122","author":"D Cesana","year":"2012","unstructured":"Cesana, D. et al. Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. J. Clin. Invest. 122, 1667\u20131676 (2012).","journal-title":"J. Clin. Invest."},{"key":"1243_CR66","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/mt.2014.3","volume":"22","author":"D Cesana","year":"2014","unstructured":"Cesana, D. et al. Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo. Mol. Ther. 22, 774\u2013785 (2014).","journal-title":"Mol. Ther."},{"key":"1243_CR67","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nbt.3062","volume":"33","author":"M Liu","year":"2015","unstructured":"Liu, M. et al. Genomic discovery of potent chromatin insulators for human gene therapy. Nat. Biotechnol. 33, 198\u2013203 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1243_CR68","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.mt.6300394","volume":"16","author":"PW Hargrove","year":"2008","unstructured":"Hargrove, P. W. et al. Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells. Mol. Ther. 16, 525\u2013533 (2008).","journal-title":"Mol. Ther."},{"key":"1243_CR69","doi-asserted-by":"crossref","unstructured":"Duverge, A. & Negroni, M. Pseudotyping lentiviral vectors: when the clothes make the virus. Viruses 12, 1311 (2020).","DOI":"10.3390\/v12111311"},{"key":"1243_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/mt.2009.280","volume":"18","author":"ML Hirsch","year":"2010","unstructured":"Hirsch, M. L., Agbandje-McKenna, M. & Samulski, R. J. Little vector, big gene transduction: fragmented genome reassembly of adeno-associated virus. Mol. Ther. 18, 6\u20138 (2010).","journal-title":"Mol. Ther."},{"key":"1243_CR71","doi-asserted-by":"crossref","unstructured":"Trapani, I. Adeno-associated viral vectors as a tool for large gene delivery to the retina. Genes 10, 287 (2019).","DOI":"10.3390\/genes10040287"},{"key":"1243_CR72","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fnins.2016.00356","volume":"10","author":"E Becirovic","year":"2016","unstructured":"Becirovic, E. et al. AAV vectors for FRET-based analysis of protein\u2013protein interactions in photoreceptor outer segments. Front. Neurosci. 10, 356 (2016).","journal-title":"Front. Neurosci."},{"key":"1243_CR73","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41434-020-00218-6","volume":"30","author":"E Barbon","year":"2023","unstructured":"Barbon, E. et al. Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor. Gene Ther. 30, 245\u2013254 (2023).","journal-title":"Gene Ther."},{"key":"1243_CR74","doi-asserted-by":"publisher","first-page":"1020803","DOI":"10.3389\/fnmol.2022.1020803","volume":"15","author":"ZR Chen","year":"2022","unstructured":"Chen, Z. R. et al. Co-transduction of dual-adeno-associated virus vectors in the neonatal and adult mouse utricles. Front. Mol. Neurosci. 15, 1020803 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"1243_CR75","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/hum.2017.095","volume":"29","author":"K Kodippili","year":"2018","unstructured":"Kodippili, K. et al. Dual AAV gene therapy for duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the canine model. Hum. Gene Ther. 29, 299\u2013311 (2018).","journal-title":"Hum. Gene Ther."},{"key":"1243_CR76","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.omtm.2020.05.007","volume":"17","author":"R Omichi","year":"2020","unstructured":"Omichi, R., Yoshimura, H., Shibata, S. B., Vandenberghe, L. H. & Smith, R. J. H. Hair cell transduction efficiency of single- and dual-AAV serotypes in adult murine cochleae. Mol. Ther. Methods Clin. Dev. 17, 1167\u20131177 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1243_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/hum.2010.122","volume":"22","author":"A Ghosh","year":"2011","unstructured":"Ghosh, A., Yue, Y. & Duan, D. Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences. Hum. Gene Ther. 22, 77\u201383 (2011).","journal-title":"Hum. Gene Ther."},{"key":"1243_CR78","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/emmm.201302948","volume":"6","author":"I Trapani","year":"2014","unstructured":"Trapani, I. et al. Effective delivery of large genes to the retina by dual AAV vectors. EMBO Mol. Med. 6, 194\u2013211 (2014).","journal-title":"EMBO Mol. Med."},{"key":"1243_CR79","doi-asserted-by":"crossref","unstructured":"Ivanchenko, M. V. et al. PCDH15 dual-AAV gene therapy for deafness and blindness in usher syndrome type 1F models. J. Clin. Invest. (2024).","DOI":"10.1101\/2023.11.09.566447"},{"key":"1243_CR80","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.omtm.2023.02.002","volume":"28","author":"R Ferla","year":"2023","unstructured":"Ferla, R. et al. Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B. Mol. Ther. Methods Clin. Dev. 28, 396\u2013411 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1243_CR81","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ymthe.2023.04.005","volume":"31","author":"LM Occelli","year":"2023","unstructured":"Occelli, L. M. et al. Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa. Mol. Ther. 31, 2028\u20132041 (2023).","journal-title":"Mol. Ther."},{"key":"1243_CR82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.gt.3301905","volume":"10","author":"S K\u00fcgler","year":"2003","unstructured":"K\u00fcgler, S., Kilic, E. & B\u00e4hr, M. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther. 10, 337\u2013347 (2003).","journal-title":"Gene Ther."},{"key":"1243_CR83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fncir.2012.00049","volume":"6","author":"B Kuhn","year":"2012","unstructured":"Kuhn, B., Ozden, I., Lampi, Y., Hasan, M. T. & Wang, S. S. An amplified promoter system for targeted expression of calcium indicator proteins in the cerebellar cortex. Front. Neural. Circuits 6, 49 (2012).","journal-title":"Front. Neural. Circuits"},{"key":"1243_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"KM Prasad","year":"2011","unstructured":"Prasad, K. M., Xu, Y., Yang, Z., Acton, S. T. & French, B. A. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 18, 43\u201352 (2011).","journal-title":"Gene Ther."},{"key":"1243_CR85","doi-asserted-by":"crossref","unstructured":"Schr\u00f6der, L. C., Frank, D. & M\u00fcller, O. J. Transcriptional targeting approaches in cardiac gene transfer using AAV vectors. Pathogens 12, 1301 (2023).","DOI":"10.3390\/pathogens12111301"},{"key":"1243_CR86","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli, C., Soltys, S., Rengo, G. & Rabinowitz, J. E. Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073\u20131080 (2008).","journal-title":"Mol. Ther."},{"key":"1243_CR87","doi-asserted-by":"crossref","unstructured":"Xu, J. Preparation, culture, and immortalization of mouse embryonic fibroblasts. Curr. Protoc. Mol. Biol. 28, 28.1 (2005).","DOI":"10.1002\/0471142727.mb2801s70"},{"key":"1243_CR88","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.cell.2020.08.013","volume":"182","author":"CS Cowan","year":"2020","unstructured":"Cowan, C. S. et al. Cell types of the human retina and its organoids at single-cell resolution. Cell 182, 1623\u20131640.e34 (2020).","journal-title":"Cell"},{"key":"1243_CR89","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nmeth886","volume":"3","author":"V Muralidharan","year":"2006","unstructured":"Muralidharan, V. & Muir, T. W. Protein ligation: an enabling technology for the biophysical analysis of proteins. Nat. Methods 3, 429\u2013438 (2006).","journal-title":"Nat. Methods"},{"key":"1243_CR90","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1039\/C3SC52951G","volume":"5","author":"NH Shah","year":"2014","unstructured":"Shah, N. H. & Muir, T. W. Inteins: nature\u2019s gift to protein chemists. Chem. Sci. 5, 446\u2013461 (2014).","journal-title":"Chem. Sci."},{"key":"1243_CR91","doi-asserted-by":"publisher","first-page":"8538","DOI":"10.1073\/pnas.1701083114","volume":"114","author":"AJ Stevens","year":"2017","unstructured":"Stevens, A. J. et al. A promiscuous split intein with expanded protein engineering applications. Proc. Natl Acad. Sci. USA 114, 8538\u20138543 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1243_CR92","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"1243_CR93","doi-asserted-by":"crossref","first-page":"10.8.1","DOI":"10.1002\/cpps.15","volume":"86","author":"A Goldman","year":"2016","unstructured":"Goldman, A., Harper, S. & Speicher, D. W. Detection of proteins on blot membranes. Curr. Protoc. Protein Sci. 86, 10.8.1\u201310.8.11 (2016).","journal-title":"Curr. Protoc. Protein Sci."},{"key":"1243_CR94","doi-asserted-by":"publisher","first-page":"8.10.1","DOI":"10.1002\/cpim.10","volume":"114","author":"D Ni","year":"2016","unstructured":"Ni, D., Xu, P. & Gallagher, S. Immunoblotting and immunodetection. Curr. Protoc. Immunol. 114, 8.10.1\u20138.10.36 (2016).","journal-title":"Curr. Protoc. Immunol."},{"key":"1243_CR95","doi-asserted-by":"publisher","first-page":"16019","DOI":"10.1038\/mtm.2016.19","volume":"5","author":"S D\u2019Costa","year":"2016","unstructured":"D\u2019Costa, S. et al. Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR. Mol. Ther. Methods Clin. Dev. 5, 16019 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1243_CR96","doi-asserted-by":"publisher","first-page":"10824","DOI":"10.1073\/pnas.1901572116","volume":"116","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Generation, transcriptome profiling, and functional validation of cone-rich human retinal organoids. Proc. Natl Acad. Sci. USA 116, 10824\u201310833 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1243_CR97","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1089\/hum.2020.321","volume":"32","author":"M V\u00f6lkner","year":"2021","unstructured":"V\u00f6lkner, M., Pavlou, M., B\u00fcning, H., Michalakis, S. & Karl, M. O. Optimized adeno-associated virus vectors for efficient transduction of human retinal organoids. Hum. Gene Ther. 32, 694\u2013706 (2021).","journal-title":"Hum. Gene Ther."},{"key":"1243_CR98","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1089\/hum.2022.109","volume":"33","author":"J Weinmann","year":"2022","unstructured":"Weinmann, J. et al. Identification of broadly applicable adeno-associated virus vectors by systematic comparison of commonly used capsid variants in vitro. Hum. Gene Ther. 33, 1197\u20131212 (2022).","journal-title":"Hum. Gene Ther."},{"key":"1243_CR99","doi-asserted-by":"crossref","unstructured":"Tessmer, K., Borsch, O., Ader, M. & Gasparini, S. J. in Brain Organoid Research (ed. Gopalakrishnan, J.) 81\u201398 (Springer US, 2023).","DOI":"10.1007\/978-1-0716-2720-4_5"},{"key":"1243_CR100","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","volume":"13","author":"AL Collins","year":"2004","unstructured":"Collins, A. L. et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679\u20132689 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"1243_CR101","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1089\/hum.2004.15.896","volume":"15","author":"Z Xu","year":"2004","unstructured":"Xu, Z. et al. Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum. Gene Ther. 15, 896\u2013905 (2004).","journal-title":"Hum. Gene Ther."},{"key":"1243_CR102","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","volume":"389","author":"A Lek","year":"2023","unstructured":"Lek, A. et al. Death after high-dose rAAV9 gene therapy in a patient with duchenne\u2019s muscular dystrophy. N. Engl. J. Med. 389, 1203\u20131210 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1243_CR103","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer, C. et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum. Gene Ther. 29, 285\u2013298 (2018).","journal-title":"Hum. Gene Ther."},{"key":"1243_CR104","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew, W. L. et al. A multifunctional AAV\u2013CRISPR\u2013Cas9 and its host response. Nat. Methods 13, 868\u2013874 (2016).","journal-title":"Nat. Methods"},{"key":"1243_CR105","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ymthe.2020.01.005","volume":"28","author":"CKW Lim","year":"2020","unstructured":"Lim, C. K. W. et al. Treatment of a mouse model of ALS by in vivo base editing. Mol. Ther. 28, 1177\u20131189 (2020).","journal-title":"Mol. Ther."},{"key":"1243_CR106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/hmg\/ddz291","volume":"29","author":"LM Riedmayr","year":"2020","unstructured":"Riedmayr, L. M., B\u00f6hm, S., Biel, M. & Becirovic, E. Enigmatic rhodopsin mutation creates an exceptionally strong splice acceptor site. Hum. Mol. Genet. 29, 295\u2013304 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"1243_CR107","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1021\/jacs.5b13528","volume":"138","author":"AJ Stevens","year":"2016","unstructured":"Stevens, A. J. et al. Design of a split intein with exceptional protein splicing activity. J. Am. Chem. Soc. 138, 2162\u20132165 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"1243_CR108","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.omtm.2021.10.004","volume":"23","author":"P Tornabene","year":"2021","unstructured":"Tornabene, P. et al. Inclusion of a degron reduces levelsof undesired inteins after AAV-mediated proteintrans-splicing in the retina. Mol. Ther. Methods Clin. Dev. 23, 448\u2013459 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1243_CR109","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/wrna.1124","volume":"3","author":"AA Klauer","year":"2012","unstructured":"Klauer, A. A. & van Hoof, A. Degradation of mRNAs that lack a stop codon: a decade of nonstop progress. Wiley Interdiscip. Rev. RNA 3, 649\u2013660 (2012).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"1243_CR110","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.immuni.2018.05.002","volume":"48","author":"B Becher","year":"2018","unstructured":"Becher, B., Waisman, A. & Lu, L. F. Conditional gene-targeting in mice: problems and solutions. Immunity 48, 835\u2013836 (2018).","journal-title":"Immunity"},{"key":"1243_CR111","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A. & Knoblich, J. A. Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9, 2329\u20132340 (2014).","journal-title":"Nat. Protoc."},{"key":"1243_CR112","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/nprot.2011.410","volume":"6","author":"KW McCracken","year":"2011","unstructured":"McCracken, K. W., Howell, J. C., Wells, J. M. & Spence, J. R. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6, 1920\u20131928 (2011).","journal-title":"Nat. Protoc."},{"key":"1243_CR113","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41596-018-0104-8","volume":"14","author":"AJ Miller","year":"2019","unstructured":"Miller, A. J. et al. Generation of lung organoids from human pluripotent stem cells in vitro. Nat. Protoc. 14, 518\u2013540 (2019).","journal-title":"Nat. Protoc."},{"key":"1243_CR114","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/nprot.2016.098","volume":"11","author":"M Takasato","year":"2016","unstructured":"Takasato, M., Er, P. X., Chiu, H. S. & Little, M. H. Generation of kidney organoids from human pluripotent stem cells. Nat. Protoc. 11, 1681\u20131692 (2016).","journal-title":"Nat. Protoc."}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01243-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:02:36Z","timestamp":1775829756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01243-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1038\/s41596-025-01243-8","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.B. and M.B. are authors on a patent application covering the splice site module and its applications (PCT\/EP2019\/086454, filed by ViGeneron GmbH, status: published). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}